School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

Organon & Co. OGN

Healthcare · Drug Manufacturers - General

$13.81last close 2026-10-09 · market cap $3.63B · delayed data

Trailing returns

1M+1.02%
3M+2.52%
6M+100.45%
1Y+40.35%
5Y-48.33%

Basis: Adjusted daily closes.

What it does

Organon & Co. develops and delivers women health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, China, Latin America, the Middle East, Russia, Africa, and internationally.

Open OGN in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies